Trial Profile
A Prospective, Multi-center, Single-arm Observational Registry Trial Evaluating the Safety and Efficacy of CRE8 Sirolimus-Eluting Stent in the Treatment of Patients With De Novo Coronary Artery Lesions
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Sponsors Carbostent & Implantable Devices
- 23 Feb 2015 New trial record